This may indicate that alterations in PLCβ1 expression and Akt activation in MDS may deregulate the cell cycle of MDS cells, resulting in the inhibition of apoptotic mechanisms and promotion of cell survival of MDS cells [83,91,92]. The gene discussed is PLCB1; the disease is myelodysplastic syndrome.